COMPOUNDS WITH PROGESTERONE-ANTAGONISTIC AND ANTI-OESTROGEN PROPERTIES INTENDED FOR COMBINED USE IN FEMALE CONTRACEPTION

摘要

This invention describes the use of at least one compound with a progesterone-antagonistic (PA) action and at least one compound with an antiestrogenic (AE) action, each in a non-ovulation-inhibiting dosage in a single dosage unit, for the production of pharmaceutical agents for female contraception.